| Trial ID: | L4605 |
| Source ID: | NCT00437918
|
| Associated Drug: |
Nateglinide
|
| Title: |
The Effects of Nateglinide and Acarbose on the Post-Prandial Glucose Control in Type 2 Diabetic Patients
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus|Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: nateglinide|DRUG: acarbose
|
| Outcome Measures: |
Primary: 7 point SMBG (self monitoring of blood glucose) | Secondary: HOMA-beta for predicting the effectiveness of each agents
|
| Sponsor/Collaborators: |
Sponsor: Inje University | Collaborators: Sanofi
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
85
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2007-01
|
| Completion Date: |
2008-03
|
| Results First Posted: |
|
| Last Update Posted: |
2008-03-24
|
| Locations: |
Paik Diabetes Center, Pusan Paik Hospital, College of Medicine, Inje University, Busan, 614-735, Korea, Republic of|Endocrinology and Metabolism, Maryknoll General Hospital, Busan, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT00437918
|
